L & S Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

L & S Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,215	Closed	-$686K	–	303
2019 Q4	$686K	Buy	+7,215	New	+$624K	0.09%	185
2018 Q4	–	Sell	-2,165	Closed	-$208K	–	338
2018 Q3	$208K	Sell	2,165 -118	-5%	-$11.4K	0.03%	298
2018 Q2	$217K	Sell	2,283 -27	-1%	-$2.48K	0.04%	281
2018 Q1	$203K	Buy	+2,310	New	+$211K	0.04%	283
2014 Q2	–	Sell	-19,716	Closed	-$936K	–	100
2014 Q1	$936K	Sell	19,716 -1,656	-8%	-$84.8K	0.5%	46
2013 Q4	$928K	Buy	21,372 +120	+0.6%	+$4.97K	0.34%	48
2013 Q3	$915K	Buy	21,252 +10,545	+98%	+$427K	0.37%	42
2013 Q2	$372K	Buy	+10,707	New	+$376K	0.18%	56

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

L & S Advisors's XBI Position: Q1 2020 in Review

L & S Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 7,215 shares — an estimated $686K sold.

L & S Advisors first reported a position in XBI in Q2 2013 and held it in 8 quarters. The position peaked at $936K in Q1 2014. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

L & S Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
L & S Advisors sold 7,215 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $686K.
L & S Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 8 quarters.
L & S Advisors's State Street SPDR S&P Biotech ETF position peaked at $936K in Q1 2014.
458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on L & S Advisors's 13F filing for Q1 2020, filed 13 May 2020.